Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Colorado, Denver
With
National Institute on Aging (NIA)
The American Geriatrics Society
This study is a double-blinded, parallel group, randomized controlled phase II trial of oral high vs. standard dose vitamin D3 supplementation administered monthly for 12 months.
Age
60–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 60+ years
Resides in nursing home
You may not be if
Terminal illness (expected survival \<6 months)
Anticipated discharge within 12 months
Unable to take whole or crushed tablets
Active cancer, except squamous/basal cell carcinoma
Severe malnutrition (body mass index \<18 kg/m2)
Current immunosuppressive medications (including corticosteroids)
